Biogen was accused of paying millions of dollars a year in kickbacks to doctors to get them to prescribe its drug Avonex, whose sales were declining, and its new treatment, called Tysabri.
Scotland-born Jope, who this year came under fierce criticism from investor activists over a failed takeover bid, will depart Unilever after five years as CEO and nearly four decades at the company, a statement said.
Manufacturers are facing an expansive labor shortage, prolonged supply chain constraints, and a job seekers market. Attend this webinar to gain a deep understanding of what’s driving the labor shortage and learn how to effectively manage these complexities.
